Article Name Asia Pacific
Antengene expands access for patients with relapsed/refractory multiple myeloma.
14th February, 2025
Dr Tan See Leng officiates the launch, introducing a vital directory to connect MedTech innovators with trusted local manufacturing partners, marking a new era for Singapore’s MedTech ecosystem.
13th February, 2025
Partnership drives innovation in brain-computer interfaces for healthcare.
13th February, 2025
Collaboration aims to explore next-gen healthcare solutions through innovation and global insights.
11th February, 2025
2024 saw Japanese medtech firm Olympus receiving approval for the company’s first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”. The estimated revenue and annual growth rate during the fiscal year ending March 2025 of Olympus Corporation is approximately 1,009 billion yen/ 9 per cent. To find out more about the company’s strategic growth plans in the new year, BioSpectrum Asia interacted with Marc Radatt, Chief Executive Officer of Olympus Corporation Asia Pacific, Singapore.
03rd February, 2025
Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region. The platform enables HCPs to share clinical experiences, and engage in secure, peer-to-peer discussions. Docquity uses AI/ML to provide insights into HCP preferences, shaping personalised healthcare engagement strategies for enterprises. In an interview with BioSpectrum, Amit Vithal, Co-founder and Chief of Growth, Docquity discusses key trends in digital health across Asia, Docquity’s expansion into government healthcare initiatives, how the company’s data-driven approach is transforming healthcare engagement and shaping future B2G collaborations across Asia.
03rd February, 2025
Malaysia is emerging as a prominent medical tourism hub, with the sector generating revenue of $444 million (RM 2 billion) in 2023. A combination of factors is driving this growth such as including strong government support and strategic private-sector partnerships. Let's explore further.
03rd February, 2025
The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities.
03rd February, 2025
Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.
29th January, 2025
Strategic MOU signed to expand high-quality, agile clinical trial services in Indonesia, fostering regional growth and collaboration for impactful therapeutic solutions.
23rd January, 2025
Promising treatment for gastrointestinal cancers aims to set new standards in precision oncology.
22nd January, 2025
Pioneering a New Era Where Global Patients Can Embrace Beauty and Confidence Through Japan's Cutting-Edge Medical Aesthetics
21st January, 2025
Partnership aims to jointly develop and launch at least 20 healthcare companies in the Kingdom.
15th January, 2025
Aktiia, Resolve Medical, SmartMore, Qritive, Elemy, Mendaera, Biolinq, Endiatx, Glooma, Neuroglee Therapeutics
10th January, 2025
EndoStream is developing a device for the treatment of cerebral aneurysms called “Nautilus”
10th January, 2025
Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies
09th January, 2025
This blog highlights the top health tech clusters in 2024 and other areas shaping the digital health landscape, setting the stage for discussions at the JP Morgan Healthcare Conference and beyond. Let’s dive into the insights that defined the year.
08th January, 2025
Innovative localized magnetic technology improves drug uptake and treatment effectiveness.
08th January, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer